Glaucoma
Welcome,         Profile    Billing    Logout  
 89 Companies   65 Products   65 Products   50 Mechanisms of Action   831 Trials   64145 News 


«12...704705706707708709710711712713714...720721»
  • ||||||||||  Simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension) / Novartis
    Trial primary completion date, Combination therapy:  Evaluation of Intraocular Pressure Using Simbrinza (clinicaltrials.gov) -  May 8, 2014   
    P4,  N=89, Completed, 
    Recruiting --> Active, not recruiting Trial primary completion date: Nov 2014 --> Mar 2014
  • ||||||||||  Trial primary completion date:  Central Corneal Thickness in Glaucoma (clinicaltrials.gov) -  May 8, 2014   
    P=N/A,  N=700, Completed, 
    Trial primary completion date: Nov 2014 --> Mar 2014 Trial primary completion date: Jan 2011 --> Jan 2013
  • ||||||||||  Trial primary completion date:  Myocilin Variations and Familial Glaucoma in Taxiarchis (clinicaltrials.gov) -  May 8, 2014   
    P=N/A,  N=800, Recruiting, 
    Trial primary completion date: Jan 2011 --> Jan 2013 Trial primary completion date: Jun 2015 --> Jun 2016
  • ||||||||||  Simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension) / Novartis
    Trial completion date, Combination therapy:  Evaluation of Intraocular Pressure Using Simbrinza (clinicaltrials.gov) -  May 8, 2014   
    P4,  N=89, Completed, 
    Trial primary completion date: Jun 2015 --> Jun 2016 Trial completion date: Nov 2014 --> Mar 2014
  • ||||||||||  Trial completion date:  Central Corneal Thickness in Glaucoma (clinicaltrials.gov) -  May 8, 2014   
    P=N/A,  N=700, Completed, 
    Trial completion date: Nov 2014 --> Mar 2014 Trial completion date: Jan 2011 --> Jan 2013
  • ||||||||||  Trial completion date:  Myocilin Variations and Familial Glaucoma in Taxiarchis (clinicaltrials.gov) -  May 8, 2014   
    P=N/A,  N=800, Recruiting, 
    Trial completion date: Jan 2011 --> Jan 2013 Trial completion date: Dec 2015 --> Dec 2016
  • ||||||||||  Simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension) / Novartis
    Trial completion, Combination therapy:  Evaluation of Intraocular Pressure Using Simbrinza (clinicaltrials.gov) -  May 8, 2014   
    P4,  N=89, Completed, 
    Trial completion date: Dec 2015 --> Dec 2016 Recruiting --> Completed
  • ||||||||||  Simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension) / Novartis
    Enrollment change:  Effect of SIMBRINZA (clinicaltrials.gov) -  Apr 27, 2014   
    P4,  N=307, Completed, 
    Active, not recruiting --> Completed N=200 --> 307
  • ||||||||||  Simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension) / Novartis
    Enrollment closed:  Effect of SIMBRINZA (clinicaltrials.gov) -  Apr 27, 2014   
    P4,  N=200, Active, not recruiting, 
    N=200 --> 307 Recruiting --> Active, not recruiting
  • ||||||||||  Simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension) / Novartis
    Trial completion:  Effect of SIMBRINZA (clinicaltrials.gov) -  Apr 27, 2014   
    P4,  N=307, Completed, 
    Recruiting --> Active, not recruiting Active, not recruiting --> Completed
  • ||||||||||  ethacrynic acid / Generic mfg.
    Trial initiation date:  Novel Drug Delivery Technique Via Retroject Device (clinicaltrials.gov) -  Apr 22, 2014   
    P1/2,  N=20, Not yet recruiting, 
    Recruiting --> Completed Initiation date: Jan 2014 --> May 2014
  • ||||||||||  Trial initiation date, Adherence:  iDropper Usability in Glaucoma (clinicaltrials.gov) -  Apr 14, 2014   
    P1,  N=22, Recruiting, 
    Not yet recruiting --> Active, not recruiting Initiation date: May 2014 --> Apr 2014
  • ||||||||||  Enrollment open, Adherence:  iDropper Usability in Glaucoma (clinicaltrials.gov) -  Apr 14, 2014   
    P1,  N=22, Recruiting, 
    Initiation date: May 2014 --> Apr 2014 Not yet recruiting --> Recruiting
  • ||||||||||  Enrollment open, Surgery:  Eye Pressure Lowering Surgery (clinicaltrials.gov) -  Apr 6, 2014   
    P=N/A,  N=40, Recruiting, 
    Active, not recruiting --> Completed Not yet recruiting --> Recruiting
  • ||||||||||  Lumigan (bimatoprost) / Senju, AbbVie
    Enrollment closed:  An Efficacy and Tolerability Study of TRAVATAN (clinicaltrials.gov) -  Mar 23, 2014   
    P4,  N=104, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting
  • ||||||||||  Trial completion:  SENSIMED Triggerfish in Closed Eyes (clinicaltrials.gov) -  Mar 2, 2014   
    P4,  N=6, Completed, 
    N=50 --> 4 Recruiting --> Completed